StreetAlpha.app
Home › Stocks › STLN

Starling Oncology, Inc. (STLN)

Healthcare
$3.40
▼ −3.95%
LAST CLOSE · NOV 17

The Oncology Institute provides outpatient cancer care, specialty pharmacy and clinical trial services from Cerritos, California. It last closed at $3.40 on Nov 17, down 3.95% on the day. The average 12-month price target from 4 analysts is $9.25 (+172.1% from the last close), with a high of $10.00 and a low of $8.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (4 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in STLN, 100% of them bullish and 0% bearish. In the past 30 days there were 1 dark pool print totaling $163K, the largest $163K.

AI Auto Pilots
Is STLN in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$620.4M
+34.6% vs a year ago
Net income
−$35.5M
−5.7% margin
EPS (diluted)
−$0.28
Free cash flow
$18.8M
3.0% margin
Valuation
Market cap
$346.8M
102.0M shares
P/E
–
No P/E while losing money
Price to sales
0.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$36.9M
At Sep 30
Debt
$72.5M
At Sep 30
Shareholder equity
−$37.4M
Shares outstanding
102.0M
At Nov 3
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $203.0M$203.0MFY2021FY2022: $252.5M$252.5MFY2022FY2023: $324.2M$324.2MFY2023FY2024: $393.4M$393.4MFY2024FY2025: $502.7M$502.7MFY2025

From STLN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 4 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
4firms
4 Buy0 Hold0 Sell
Each firm's latest rating on STLN in the past 90 days
Average 12-month target
$9.25
▲ 172.1% upside

Based on 4 analysts who set a price target on STLN in the past 90 days. The average target is $9.25, with a high of $10.00 and a low of $8.00, compared with the last close of $3.40.

Low $8.00Avg $9.25High $10.00
Blue marker: last close $3.40
Highest target$10.00
Average target$9.25
Lowest target$8.00
Latest rating changes
BTIGReiterated
Nov 9Buy$10
Lake StreetMaintained
Nov 7Buy$8
B. Riley SecuritiesReiterated
Nov 6Buy$10
BTIGMaintained
Nov 6Buy$10
NeedhamMaintained
Oct 14Buy$9
DateFirmActionRatingPrice target
Nov 9BTIGReiteratedBuy$10
Nov 7Lake StreetMaintainedBuy$8
Nov 6B. Riley SecuritiesReiteratedBuy$10
Nov 6BTIGMaintainedBuy$10
Oct 14NeedhamMaintainedBuy$9
Loading…

Technical Analysis

STLN · as of the Nov 17 close · updated after every close
Falling, oversold

The stock is 61% below its 20 day and 80% below its 50 day average. Momentum is weak (RSI 29), oversold. The nearest support is the swing low (Nov 6) at $3.35, and the nearest resistance the Pivot at $3.48.

Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 16.3%/day
Key levels
$7.1352 week high+109.7%
$6.67Swing high (Jul 14)+96.2%
$6.1250 day average+80.0%
$5.4920 day average+61.5%
$3.59Pivot R1+5.6%
$3.48Pivot+2.4%
$3.40Last close
$3.35Swing low (Nov 6)−1.5%
$3.3152 week low−2.6%
$3.28Pivot S1−3.5%
Indicators
RSI (14)28.95Oversold below 30Oversold
MACD-0.80Below its signal lineBearish
Stochastic4.6Near the bottom of its rangeOversold
ADX (14)33.8Trending down
Williams %R-97.6Oversold below −80, overbought above −20Oversold
CCI (20)-107.9Oversold below −100, overbought above 100Oversold
Rate of change−46.4%Change over 10 sessionsBearish
ATR (14)$0.55Typical daily range, 16.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for STLN

What happened before

See how STLN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow STLN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How STLN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
1
Bullish
1
100%
Bearish
0
0%
Date span
Nov 10 – Nov 10
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$163K
Largest print
$163K
Loading…

STLN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲73 buying vs 46 selling
  • ▲Held by funds +2.9 pts
  • ▲Funds holding +9
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding129120+7.5%
In funds' top 1032+50.0%
Held by funds42.2%39.3%+2.9 pts
New / increased26 / 4727 / 51−6.4%
Reduced / sold out31 / 1525 / 22−2.1%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See STLN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STLN is in one of them and how their past STLN trades turned out.

STLN in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered STLN in an article yet. Here's the latest on the wider market.

STLN Congress Trades

All congress trades →
Trades, 12 months
12
Buys
0
0%
Sells
12
100%
People
1
Last filed Oct 26
Who traded STLN · since 2026
Latest 5 filings of 12
Richard BlumenthalSell (partial)
$1K – $15KTraded Sep 23, 2026Filed Oct 26, 2026
Richard BlumenthalSell (partial)
$1K – $15KTraded Sep 23, 2026Filed Oct 26, 2026
Richard BlumenthalSell (partial)
$15K – $50KTraded Sep 22, 2026Filed Oct 26, 2026
Richard BlumenthalSell (partial)
$15K – $50KTraded Sep 22, 2026Filed Oct 26, 2026
Richard BlumenthalSell (partial)
$15K – $50KTraded Sep 22, 2026Filed Oct 26, 2026
PersonTypeAmountTradedFiledDelay
Richard BlumenthalD · CTSell (partial)$1K – $15KSep 23, 2026Oct 26, 202633 d
Richard BlumenthalD · CTSell (partial)$1K – $15KSep 23, 2026Oct 26, 202633 d
Richard BlumenthalD · CTSell (partial)$15K – $50KSep 22, 2026Oct 26, 202634 d
Richard BlumenthalD · CTSell (partial)$15K – $50KSep 22, 2026Oct 26, 202634 d
Richard BlumenthalD · CTSell (partial)$15K – $50KSep 22, 2026Oct 26, 202634 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Starling Oncology

The Oncology Institute is a cancer care company based in Cerritos, California. It provides outpatient cancer treatment, including medical oncology, radiation oncology, infusion therapy and specialty pharmacy services, through clinics in five states. Its patients are mostly referred by other doctors and health plans. It is paid either for each service it delivers or by health plans under contracts that set a fixed amount per patient. It also runs clinical trial services for drug companies.

Headquarters
Cerritos, CA